## Research-question validation

### Phenomenon-vs-method check

**Verdict**: pass  
The question asks about the relationship between fundamental molecular descriptors and composite drug‑likeness scores, which is a substantive scientific inquiry independent of any specific computational method or resource constraint.

### Circularity check

**Verdict**: fail  
The predictors (e.g., TPSA, logP, rotatable bonds) are the same quantitative features that are used to compute the composite drug‑likeness scores (Lipinski, Veber, Ghose). Because the scores are deterministic functions of these descriptors, the predictive relationship is mechanically guaranteed.

### Triviality check

**Verdict**: fail  
Since the drug‑likeness scores are defined directly from the descriptors, a strong correlation is expected a priori; both a positive and a null result would be uninformative, rendering the question essentially trivial.

### Question-narrowing check

**Verdict**: pass  
The question focuses on a domain‑level relationship (descriptors ↔ drug‑likeness) rather than on implementation constraints such as algorithm choice or runtime limits.

### Overall verdict

**Verdict**: validator_revise  
The core issue is circularity and triviality arising from predicting rule‑based scores that are themselves derived from the same descriptors. A defensible reframing would target an outcome that is not a deterministic function of the descriptors.

[REVISED]  
To what extent can fundamental molecular descriptors (e.g., TPSA, logP, rotatable bonds) predict experimentally measured drug‑likeness outcomes such as oral bioavailability, permeability, or in‑vivo clearance across diverse chemical scaffolds?  
[/REVISED]

Reframing the question to predict empirical ADMET endpoints breaks the circularity, making both positive and null findings scientifically informative while retaining the original focus on simple descriptor‑based models.
